QA: Nurix Therapeutics Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001549595_2026_Nurix_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001549595, Nurix Therapeutics Inc

  xvar xval
0 AssetsCurrent 606,819,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 22,490,000
3 remainder_Assets 58,826,000
4 LiabilitiesCurrent 86,471,000
5 LiabilitiesNoncurrent 62,917,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 67,223,429
9 ResearchAndDevelopmentExpense 585,236,544
10 remainder_Expenses 590,743
11 remainder_Revenues 104,034,147
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 263,767
  yvar yval
0 Assets 688,135,000
1 Liabilities 149,388,000
2 Expenses 653,050,716
3 Revenues 104,034,147
4 StockholdersEquity 538,747,000
5 NetIncome -549,016,569
6 ComprehensiveNetIncome -548,884,686
7 BaseVar 797,435,815
8 EconomicCapitalRatiobeforeLimitedLiability 1.49
9 EconomicCapitalRatio 2.67

Edgar->Model Mapping

Feature Distribution

Change over Time